Company registration number:
4115929
KAAM PHARMA LIMITED
Unaudited filleted financial statements
31 December 2024
KAAM PHARMA LIMITED
Contents
Directors and other information
Accountant's report
Statement of financial position and notes to the financial statements
KAAM PHARMA LIMITED
Directors and other information
|
|
|
|
Directors |
Mr M K Patel |
|
|
Mr A Makadia |
|
|
Mrs Hital Patel |
|
|
|
|
|
|
|
Secretary |
Mr A Makadia |
|
|
|
|
|
|
|
Company number |
4115929 |
|
|
|
|
|
|
|
Registered office |
9 Westfield Drive |
|
|
Harrow |
|
|
Middlesex |
|
|
HA3 9EG |
|
|
|
|
|
|
|
Business address |
Unit 2, Barratt Way Industrial Estate |
|
|
Tudor Road |
|
|
Harrow |
|
|
Middlesex |
|
|
HA3 5TJ |
|
|
|
|
|
|
|
Accountant |
Mak Plus Limited |
|
|
9 Westfield Drive |
|
|
Harrow |
|
|
Middlesex |
|
|
HA3 9EG |
|
|
|
KAAM PHARMA LIMITED
Accountant's report to the board of directors on the preparation of the
unaudited statutory financial statements of Kaam Pharma Limited
Year ended 31 December 2024
As described on the Statement of financial position, the directors of the company are responsible for the preparation of the financial statements for the year ended 31 December 2024, as set out on pages to 11.
You consider that the company is exempt from an audit under the Companies Act 2006. In accordance with your instructions I have compiled these unaudited financial statements in order to assist you to fulfil your statutory responsibilities, from the accounting records and from information and explanations supplied to me.
Mak Plus Limited
Accountants and Tax Consultants
9 Westfield Drive
Harrow
Middlesex
HA3 9EG
18 September 2025
KAAM PHARMA LIMITED
Statement of financial position
31 December 2024
|
|
|
2024 |
|
|
2023 |
|
|
|
|
£ |
£ |
|
£ |
£ |
|
|
|
|
|
|
|
|
|
Fixed assets |
|
|
|
6,273 |
|
|
17,517 |
|
|
|
|
_________ |
|
|
_________ |
|
|
|
|
|
|
|
|
|
Current assets |
|
|
3,280,559 |
|
|
3,327,593 |
|
|
Prepayments and accrued income |
|
|
76,353 |
|
|
8,633 |
|
|
|
|
_________ |
|
|
_________ |
|
|
|
|
|
3,356,912 |
|
|
3,336,226 |
|
|
|
|
|
|
|
|
|
Creditors: amounts falling due within one year |
|
|
|
(
774,680) |
|
|
(
869,582) |
|
|
|
|
_________ |
|
|
_________ |
|
|
|
|
|
|
|
|
|
Net current assets |
|
|
|
2,582,232 |
|
|
2,466,644 |
|
|
|
|
_________ |
|
|
_________ |
|
|
|
|
|
|
|
|
|
Total assets less current liabilities |
|
|
|
2,588,505 |
|
|
2,484,161 |
|
|
|
|
|
|
|
|
|
Accruals and deferred income |
|
|
|
(
8,989) |
|
|
(
12,089) |
|
|
|
|
|
|
|
|
|
|
|
|
_________ |
|
|
_________ |
|
Net assets |
|
|
|
2,579,516 |
|
|
2,472,072 |
|
|
|
|
_________ |
|
|
_________ |
|
|
|
|
|
|
|
|
|
Capital and reserves |
|
|
|
2,579,516 |
|
|
2,472,072 |
|
|
|
|
_________ |
|
|
_________ |
|
|
|
|
|
|
|
|
KAAM PHARMA LIMITED
Year ended 31 December 2024
Notes to the financial statements
1.
Employee numbers
The average number of persons employed by the company during the year amounted to
7
(2023:
9
).
For the year ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors responsiblities:
-
The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
-
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
The financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the
board of directors
and authorised for issue on
18 September 2025
, and are signed on behalf of the board by:
Mr M K Patel
Director
Company registration number:
4115929
The company is a private company limited by shares, registered in England & Wales.